Equities

Lifestance Health Group Inc

LFST:NSQ

Lifestance Health Group Inc

Actions
  • Price (USD)6.21
  • Today's Change0.19 / 3.16%
  • Shares traded227.98k
  • 1 Year change-13.03%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 15:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

  • Revenue in USD (TTM)1.06bn
  • Net income in USD-186.26m
  • Incorporated2021
  • Employees9.33k
  • Location
    Lifestance Health Group Inc4800 N. Scottsdale Road, Suite 6000SCOTTSDALE 85251United StatesUSA
  • Phone+1 (602) 767-2100
  • Fax+1 (302) 636-5454
  • Websitehttps://investor.lifestance.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Brookdale Senior Living, Inc.3.02bn-189.01m1.25bn25.20k--3.077.730.4137-0.8392-0.839213.392.140.524--57.91119,675.80-3.29-2.20-3.68-2.4824.7621.71-6.27-4.40--0.12130.9048--6.74-7.8220.73---12.60--
National HealthCare Corporation1.14bn66.80m1.43bn13.12k21.521.5813.351.254.344.3474.2359.200.882898.4310.9586,988.045.055.126.026.2137.6039.845.726.281.86--0.000949.355.143.09197.612.03-1.293.43
US Physical Therapy Inc604.80m18.14m1.67bn3.90k82.803.4931.602.761.341.3442.6431.770.6519--8.74155,117.204.017.135.6310.6420.0921.966.159.71--16.620.183658.539.345.91-38.011.785.2613.33
Addus Homecare Corporation1.06bn62.52m1.68bn6.06k27.052.3821.961.593.843.8464.9643.551.08--8.79174,723.706.375.187.426.0432.2430.885.914.96--9.640.14940.0011.3115.4335.8330.8312.06--
Veracyte Inc361.05m-74.40m1.70bn815.00--1.52--4.72-1.02-1.024.9714.250.31797.428.56443,007.40-6.55-6.33-6.93-6.6968.7367.10-20.61-20.994.40--0.0001--21.7631.45-103.51--39.67--
Brightspring Health Services Inc8.83bn-154.60m1.74bn35.00k--2.0538.230.1971-0.9204-0.920457.534.96------252,176.40--------16.2417.75-1.78-0.62890.84420.97830.8473--14.3228.33-186.80--17.24--
NeoGenomics, Inc.591.64m-87.97m1.94bn2.10k--2.06--3.28-0.7015-0.70154.717.390.345914.334.68281,734.80-5.14-3.57-5.44-3.8041.3441.09-14.87-9.365.95--0.3637--16.0716.4139.02--14.98--
Astrana Health Inc1.39bn60.72m1.99bn1.80k31.773.1426.271.431.291.2929.5613.111.46--11.07770,367.806.097.096.739.3915.5018.304.176.36----0.405510.5421.1921.6834.4241.1689.42--
Lifestance Health Group Inc1.06bn-186.26m2.29bn9.33k--1.60--2.17-0.5059-0.50592.873.770.4929--9.33113,208.00-8.70---9.54-------17.64-----5.690.1654--22.82--13.59------
Privia Health Group Inc1.66bn23.08m2.32bn1.10k105.564.1284.111.400.18520.185213.304.751.85--6.901,504,299.002.35--3.91--9.749.151.27-2.56----0.00--22.1920.31368.83---12.48--
Agilon Health Inc4.32bn-195.05m2.35bn1.12k--3.52--0.5437-0.4885-0.657610.511.632.51--5.993,864,246.00-11.36---20.26--7.13---4.52-----13,643.820.0551--80.74---112.01------
Teladoc Health Inc2.60bn-220.37m2.55bn5.60k--1.0921.860.9801-1.34-1.3415.8113.960.595717.7012.16464,717.00-5.04-33.54-5.57-34.6370.8068.59-8.47-171.393.47--0.3981--8.1344.1698.39--79.43--
Amedisys Inc2.24bn-9.75m3.02bn19.00k--2.83233.941.35-0.3078-0.307868.4532.651.11--7.33117,704.30-0.54197.82-0.705810.3944.3143.63-0.4895.89--10.030.26230.000.5936.11-108.22--14.16--
Quidelortho Corp3.00bn-10.10m3.23bn7.10k--0.6437.221.08-0.1542-0.154244.8175.050.34422.737.03422,225.30-0.11611.34-0.129712.9149.8562.71-0.336920.930.87881.710.32540.00-8.2141.83-101.84--45.87--
Data as of Mar 28 2024. Currency figures normalised to Lifestance Health Group Inc's reporting currency: US Dollar USD

Institutional shareholders

19.79%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 202328.54m7.54%
Durable Capital Partners LPas of 31 Dec 20237.60m2.01%
The Vanguard Group, Inc.as of 31 Dec 20237.35m1.94%
BlackRock Fund Advisorsas of 31 Dec 20236.98m1.84%
FIAM LLCas of 31 Dec 20236.05m1.60%
Brown Advisory LLCas of 31 Dec 20235.16m1.36%
Rock Springs Capital Management LPas of 31 Dec 20234.54m1.20%
Principal Global Investors LLCas of 31 Dec 20234.01m1.06%
Geode Capital Management LLCas of 31 Dec 20232.42m0.64%
SSgA Funds Management, Inc.as of 31 Dec 20232.28m0.60%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.